Scientist Who Led Genentech to Avastin Joins Tiziana as Adviser

Napoleone Ferrara, professor at UC San Diego School of Medicine, joins Tiziana Life Sciences as chairman of scientific advisory board and consultant, co. says in statement. * Co. developing experimental treatment for late-stage breast cancer targeting BCL3 gene * “I look forward to advising the company’s scientists as they work towards human trials for this promising therapeutic gene technology”: Ferrara * NOTE: Tiziana started trading on AIM on April 24 * NOTE: Ferrara in 2010 won Lasker Award, which often foretells future Nobel Prize winners * NOTE: Avastin for colorectal, breast, lung, kidney, ovarian cancers and glioblastoma had CHF6.25b ($7b) in sales last yr

Before it's here, it's on the Bloomberg Terminal.